Sientra IncChange company Symbol lookupSelect an option...SIEN Sientra IncGOOG Alphabet IncWHLR Wheeler Real Estate Investment Trust IncFRHLF Freehold Royalties LtdCTNT Cheetah Net Supply Chain Service IncLASE Laser Photonics CorpGFR M3-Brigade Acquisition III CorpPCT Purecycle Technologies IncUPST Upstart Holdings IncCPSI Computer Programs and Systems IncGo
Change company Symbol lookup
Select an option...
SIEN Sientra Inc
GOOG Alphabet Inc
WHLR Wheeler Real Estate Investment Trust Inc
FRHLF Freehold Royalties Ltd
CTNT Cheetah Net Supply Chain Service Inc
LASE Laser Photonics Corp
GFR M3-Brigade Acquisition III Corp
PCT Purecycle Technologies Inc
UPST Upstart Holdings Inc
CPSI Computer Programs and Systems Inc
Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profileSientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
|
|
|
|
| |
| Latest Earnings Met Consensus (Q2 ending 06/2023) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q2 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced August 10, 2023 | -$0.85 | Q2 Estimate range of 3 analysts | -$0.88 to -$0.84 | Q3 Earnings will announce | (Unconfirmed) November 8, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
SIEN's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.